Evidence map›Paper›PMID 32857272›Full record

ReviewPituitary2020

Ectopic hyperprolactinaemia due to a malignant uterine tumor resembling ovarian sex cord tumors (UTROCST).

Georgios K Dimitriadis, Delane S Wajman, John Bidmead, Salvador J Diaz-Cano, Sobia Arshad, Mohamed Bakhit, Dylan Lewis, Simon J B Aylwin

Open access · hybridAbstract readCase ReportsReview
In one paragraph

Review in Pituitary, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Georgios K DimitriadisDepartment of Endocrinology, King's College Hospital NHS Foundation Trust, Porta Cabin B, Denmark Hill, London, SE5 9RS, UK. g.dimitriadis@warwick.ac.uk.ORCID http://orcid.org/0000-0002-6662-804X
Delane S WajmanDepartment of Endocrinology, King's College Hospital NHS Foundation Trust, Porta Cabin B, Denmark Hill, London, SE5 9RS, UK.
John BidmeadDepartment of Urogynaecology, King's College Hospital NHS Foundation Trust, London, SE5 9RS, UK.
Salvador J Diaz-CanoKing's Health Partners, Cancer Studies, King's College Hospital NHS Foundation Trust-Viapath, London, SE5 9RS, UK.
Sobia ArshadDepartment of Endocrinology, King's College Hospital NHS Foundation Trust, Porta Cabin B, Denmark Hill, London, SE5 9RS, UK.
Mohamed BakhitDepartment of Endocrinology, King's College Hospital NHS Foundation Trust, Porta Cabin B, Denmark Hill, London, SE5 9RS, UK.
Dylan LewisDepartment of Radiology, King's College Hospital NHS Foundation Trust, London, SE5 9RS, UK.
Simon J B AylwinDepartment of Endocrinology, King's College Hospital NHS Foundation Trust, Porta Cabin B, Denmark Hill, London, SE5 9RS, UK. simonaylwin@nhs.net.
King's College Hospital NHS Foundation Trust · GBUniversity of Warwick · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeModerate hyperprolactinaemia (2-5 times upper limit of normal) occurring in a patient with a normal pituitary MRI is generally considered to be due to a lesion below the level of detection of the MRI scanner assuming macroprolactin and stress have been excluded. Most patients with mild-to-moderate hyperprolactinaemia and a normal MRI respond to dopamine agonist therapy. We present the rare case of a patient who had prolactin elevation typical of a prolactin-secreting pituitary macroadenoma,with a normal cranial MRI, and in whom the prolactin rose further with dopamine agonist treatment. Subsequent investigations revealed ectopic hyperprolactinaemia to a uterine tumor resembling ovarian sex cord tumor (UTROSCT) which resolved following tumor resection. Although mostly considered to be benign, the UTROSCT recurred with recurrent hyperprolactinaemia and intraabdominal metastases.

methodsWe have systematically and critically reviewed existing literature relating to ectopic hyperprolactinaemia in general and UTROCST specifically.

resultsFewer than 80 cases of UTROSCTs have been reported globally of which about 23% have shown malignant behaviour. There are fewer than 10 cases of paraneoplastic hyperprolactinaemia originating from uterine neoplasms including one other case of ectopic hyperprolactinaemia to a UTROSCT.

conclusionsOur case demonstrates the importance of screening for extracranial hyperprolactinaemia in the context of: (1) substantially raised prolactin (10× ULN) and (2) normal cranial MRI assuming macroprolactin has been excluded. The majority of extracranial ectopic prolactin-secreting tumors occur in the reproductive organs.

Indexed as

AdultDopamine AgonistsFemaleHumansHyperprolactinemiaImmunohistochemistryMagnetic Resonance ImagingMiddle AgedProlactinomaUterine NeoplasmsDopamine AgonistsEctopicExtracranialHyperprolactinaemiaParaneoplasticProlactinomaUterine neoplasmUTROCST

Identifiers

PMID32857272
PMCPMC7585568
OpenAlexW3081863919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.